Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-r5zm4 Total loading time: 0 Render date: 2024-06-27T20:38:29.076Z Has data issue: false hasContentIssue false

67 - Smallpox

from Part IV - Current Topics

Published online by Cambridge University Press:  15 December 2009

David M. Stier
Affiliation:
Medical Epidemiologist, Medical Director, Adult Immunization and Travel Clinic, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
Nikkita Patel
Affiliation:
Research Assistant, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
Olivia Bruch
Affiliation:
Health Program Coordinator, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
Karen A. Holbrook
Affiliation:
Medical Epidemiologist, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
Rachel L. Chin
Affiliation:
University of California, San Francisco
Get access

Summary

INTRODUCTION

Smallpox is caused by variola viruses, which are large, enveloped, single-stranded DNA viruses of the Poxvirus family and the Orthopoxvirus genus. Variola major strains cause three forms of disease (ordinary, flat type, and hemorrhagic), whereas variola minor strains cause a less severe form of smallpox. Vaccination with vaccinia virus, another member of the Orthopoxvirus genus, protects humans against smallpox because of the high antibody cross-neutralization between orthopoxviruses.

The Working Group for Civilian Biodefense considers smallpox a dangerous potential biological weapon because of “its case-fatality-rate of 30% or more among unvaccinated persons and the absence of specific therapy.” Of the potential ways in which smallpox could be used as a biological weapon, an aerosol release is expected to have the most severe medical and public health outcomes because of the virus's stability in aerosol form, low infectious dose, and high rate of secondary transmission. A single case of smallpox would be a public health emergency.

EPIDEMIOLOGY

Smallpox as a Biological Weapon

Smallpox has been used as a biological weapon in the distant past and has recently been a focus of bioweapons research. In the 18th century, British troops in North America gave smallpox-infected blankets to their enemies, who went on to suffer severe outbreaks. Defecting Russian scientists describe covert Russian operations during the 1970s and 1980s that focused on the development of more virulent smallpox strains and of missiles and bombs that could release smallpox.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bhatnagar, V, Stoto, M A, Morton, S C, et al. Transmission patterns of smallpox: systematic review of natural outbreaks in Europe and North America since World War II. BMC Public Health 2006;6:126.CrossRefGoogle ScholarPubMed
Breman, J G, Henderson, D A. Diagnosis and management of smallpox. N Engl J Med 2002;346:1300–8.CrossRefGoogle ScholarPubMed
Casey, C G, Iskander, J K, Roper, M H, et al. Adverse events associated with smallpox vaccination in the United States, January–October 2003. JAMA 2005;294:2734–43.Google ScholarPubMed
Centers for Disease Control and Prevention (CDC). Acute, generalized vesicular or pustular rash illness testing protocol in the United States. Available at: http://www.bt.cdc. gov/agent/smallpox/diagnosis/rashtestingprotocol.asp.
Centers for Disease Control and Prevention (CDC) Poster: evaluating patients for smallpox. Available at: http://www.bt.cdc.gov/agent/smallpox/diagnosis/evalposter.asp.
Cohen, H W, Gould, R M, Sidel, V W. Smallpox vaccinations and adverse events. JAMA 2006;295:1897–8.Google ScholarPubMed
Fenner, F, Henderson, D A, Arita, I, et al. Smallpox and its eradication. Geneva: World Health Organization, 1988. Retrieved February 10, 2007, from http://whqlibdoc.who. int/smallpox/924156.pdf.Google Scholar
Huhn, G D, Bauer, A M, Yorita, K, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis 2005;41:1742–51.CrossRefGoogle ScholarPubMed
Kim, S-H, Bang, J-W, Park, K-H, et al. Prediction of residual immunity to smallpox by means of an intradermal skin test with inactivated vaccinia virus. J Infect Dis 2006;194:377–84; comments and author reply in 195:160–2.CrossRefGoogle ScholarPubMed
Kiang, K M, Krathwohl, M D. Rates and risks of transmission of smallpox and mechanisms of prevention. J Lab Clin Med 2003;142:229–38.CrossRefGoogle ScholarPubMed
Moore, Z S, Seward, J F, Lane, J M. Smallpox. Lancet 2006;367:425–35.CrossRefGoogle ScholarPubMed
Nishiura, H. Smallpox during pregnancy and maternal outcomes. Emerg Infect Dis 2006;12:1119–21.CrossRefGoogle ScholarPubMed
Nishiura, H, Schwehm, M, Eichner, M. Still protected against smallpox? Estimation of the duration of vaccine-induced immunity against smallpox. Epidemiology 2006;17: 576–81.CrossRefGoogle ScholarPubMed
Nishiura, H, Eichner, M. Infectiousness of smallpox relative to disease age: estimates based on transmission network and incubation period. Epidemiol Infect 2006;1–6.Google ScholarPubMed
Sejvar, J J, Labutta, R J, Chapman, L E, et al. Neurologic adverse events associated with smallpox vaccination in the United States, 2002–2004. JAMA 2005;294:2744–50.Google ScholarPubMed
Center for Infectious Disease Research and Policy (CIDRAP). Smallpox: current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis. Retrieved May 18, 2005, from http://www.cidrap.umn.edu/cidrap/content/bt.
Damon I. Orthopoxviruses: vaccinia (smallpox vaccine), variola (smallpox), monkeypox, and cowpox. In: Mandell, G L, Bennett, J E, Dolin, R, eds, Principles and practice of infectious diseases (6th ed). New York: Churchill Livingstone, 2005.Google Scholar
Henderson, D A, Inglesby, T V, Bartlett, J G, et al., for the Working Group on Civilian Biodefense. Smallpox as a biological weapon: medical and public health management. JAMA 1999;281(22):2127–39.Google Scholar
Rotz L D, Cono J, Damon I. Smallpox and bioterrorism. In: Mandell, G L, Bennett, J E, Dolin, R, eds, Principles and practice of infectious diseases (6th ed). New York: Churchill Livingstone, 2005.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Smallpox
    • By David M. Stier, Medical Epidemiologist, Medical Director, Adult Immunization and Travel Clinic, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Nikkita Patel, Research Assistant, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Olivia Bruch, Health Program Coordinator, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Karen A. Holbrook, Medical Epidemiologist, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.068
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Smallpox
    • By David M. Stier, Medical Epidemiologist, Medical Director, Adult Immunization and Travel Clinic, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Nikkita Patel, Research Assistant, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Olivia Bruch, Health Program Coordinator, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Karen A. Holbrook, Medical Epidemiologist, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.068
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Smallpox
    • By David M. Stier, Medical Epidemiologist, Medical Director, Adult Immunization and Travel Clinic, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Nikkita Patel, Research Assistant, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Olivia Bruch, Health Program Coordinator, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA, Karen A. Holbrook, Medical Epidemiologist, Communicable Disease Control and Prevention Section, San Francisco Department of Public Health, San Francisco, CA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.068
Available formats
×